Siemens Medical is a world-renowned medical technology company. For 130 years, it has led the innovation of medical technology. The company continues to develop innovative products and services, including artificial intelligence-based applications and digital products that play an increasingly important role in the development of the new generation of medical technology, and further consolidates the fields of in vitro diagnosis, image-guided treatment, in vivo diagnosis and new cancer diagnosis and treatment. The basis of At the same time, Siemens Medical provides a wide range of services and solutions to help medical service providers improve their capabilities and provide patients with high-quality and efficient services.

In order to achieve the goal of "Siemens Medical 2025 Strategy", by accelerating business expansion, exploring growth markets related to core businesses such as artificial intelligence, future diagnosis and treatment or technical support services, and completing the next phase of the goal in a more targeted way and method. , further consolidate our market leadership position. In China, Siemens Medical is committed to becoming a trusted partner for China's medical and health system and Chinese patients by meeting the most pressing medical needs. The company has launched a new China strategy for the next three years, and will be "customer-centric" in all aspects, targeting the differentiated needs of different customer groups, establishing a more focused and professional team, and providing an overall solution driven by digitalization. , meet the needs of Chinese customers.

In 2022, Siemens Medical China officially released the localization strategy of "National Intelligence Innovation", aiming to deeply participate in the construction of a healthy China as a Chinese company. The upgraded strategy is divided into three dimensions: First, the company will gradually promote the localization of the entire product line, further enrich and improve the product lineage, meet the diversified needs of Chinese customers and patients, and help the local industrial chain transform and upgrade. Second, based on the demand of the Chinese market, the company further deepens its innovation and research and development. On the one hand, it accelerates the implementation of global leading technologies in China, benefiting doctors and patients as soon as possible, and on the other hand, it continues to explore local innovation. Third, the company continues to promote the upgrading of local business models, improve the large-scale application of medical equipment in all fields of the disease process, gradually improve the industrial ecology, and explore and practice multi-dimensional medical and industrial collaborative innovation model.